Congress Shouldn’t Pass FDA Reform Bills Without Addressing Patient Safety and Drug Prices

The Health Care Blog
By DIANA ZUCKERMAN A major proposed law that alters the way the Food and Drug Administration (FDA) approves drugs and medical devices has been wending its way through Congress since 2014. Momentum is building on Capitol Hill to pass the legislation in Read More...

Read the complete post at http://thehealthcareblog.com/blog/2016/11/23/congress-shouldnt-pass-fda-reform-bills-without-addressing-patient-safety-and-drug-prices/


Posted Nov 23 2016, 08:01 AM by THCB
Filed under: